Related Experiment Video
Updated: Feb 8, 2026

Immunoglobulin Gene Sequence Analysis In Chronic Lymphocytic Leukemia: From Patient Material To Sequence Interpretation
Published on: November 26, 2018
Identification of Prognostic and Susceptibility Markers in Chronic Myeloid Leukemia Using Next Generation Sequencing
Yogender Shokeen1, Neeta Raj Sharma2, Abhishek Vats3
1Department of Medical Oncology, Sir Ganga Ram Hospital, Rajinder Nagar, Delhi, India.
Background:
Incidence of Chronic Myeloid Leukemia (CML) is continuously increasing and expected to reach 100,000 patients every year by 2030. Though the discovery of Imatinib Mesylate (IM) has brought a paradigm shift in CML treatment, 20% patients show resistance to this tyrosine kinase inhibiter (TKI). Therefore, it is important to identify markers, which can predict the occurrence and prognosis of CML. Clinical Exome Sequencing, panel of more than 4800 genes, was performed in CML patients to identify prognostic and susceptibility markers in CML.
Methods:
Enrolled CML patients (n=18) were segregated as IM responders (n=10) and IM failures (n=8) as per European Leukemia Net (ELN), 2013 guidelines. Healthy controls (n=5) were also enrolled. DNA from blood of subjects was subjected to Next Generation Sequencing. Rare mutations present in one patient group and absent in another group were considered as prognostic markers, whereas mutations present in more than 50% patients were considered as susceptibility markers.
Result:
Mutations in genes associated with cancer related functions were found in different patient groups. Four variants: rs116201358, rs4014596, rs52897880 and rs2274329 in C8A, UNC93B1, APOH and CA6 genes, respectively, were present in IM responders; whereas rs4945 in MFGE8 was present in IM failures. Mutations in HLA-DRB1 (rs17878951), HLA-DRB5 (rs137863146), RPHN2 (rs193179333), CYP2F1 (rs116958555), KCNJ12 (rs76684759) and FUT3 (rs151218854) were present as susceptibility markers.
Conclusion:
The potential genetic markers discovered in this study can help in predicting response to IM as frontline therapy. Susceptibility markers may also be used as panel for individuals prone to have CML.
Insights
Genetic markers can predict Chronic Myeloid Leukemia (CML) treatment response and susceptibility. This study identified specific variants in CML patients, offering potential for personalized medicine and early detection strategies.
Area of Science:
- Oncology
- Genetics
- Hematology
Background:
- Chronic Myeloid Leukemia (CML) incidence is rising, with significant patient resistance to Imatinib Mesylate (IM) therapy.
- Identifying prognostic and susceptibility markers is crucial for effective CML management.
- Clinical Exome Sequencing was employed to discover these genetic markers.
Purpose of the Study:
- To identify genetic markers that predict the occurrence and prognosis of Chronic Myeloid Leukemia (CML).
- To discover prognostic markers for Imatinib Mesylate (IM) response and susceptibility markers for CML development.
- To explore the utility of Clinical Exome Sequencing in CML genetic research.
Main Methods:
- 18 CML patients (10 IM responders, 8 IM failures) and 5 healthy controls were enrolled.
- DNA was analyzed using Next Generation Sequencing (Clinical Exome Sequencing).
- Prognostic markers were defined as rare mutations present in one group but absent in another; susceptibility markers were mutations present in over 50% of patients.
Main Results:
- Four variants (rs116201358, rs4014596, rs52897880, rs2274329) in C8A, UNC93B1, APOH, and CA6 genes were found in IM responders.
- The rs4945 variant in MFGE8 was identified in IM failures.
- Susceptibility markers included mutations in HLA-DRB1, HLA-DRB5, RPHN2, CYP2F1, KCNJ12, and FUT3 genes.
Conclusions:
- The identified genetic markers show potential for predicting IM response in CML patients.
- Susceptibility markers could be utilized in panels for individuals at risk of developing CML.
- These findings may contribute to personalized treatment strategies and early detection of CML.
Related Concept Videos
Next-generation Sequencing
Next-Generation Sequencing Methods
Although all next-generation methods use different technologies, they all share a set of standard features....
Magnetic Susceptibility and Permeability
When diamagnetic materials are placed under an external magnetic field, the moments opposite to the field are induced. Hence, the susceptibility for diamagnets has a minimal negative value of 10-5–10-6. Since...
Susceptibility, Permittivity and Dielectric Constant
Cis-regulatory Sequences
Sequences
Differentiation of Common Myeloid Progenitor Cells

